Consort's nicotine delivery device deal with BAT to be "largest single revenue opportunity"
This article was originally published in Clinica
Executive Summary
UK drug delivery device specialist Consort Medical this morning announced its subsidiary Bespak has struck a multi-year contract to be the exclusive supplier of an innovative nicotine inhalation device for Nicoventures, a unit within the world's number two tobacco player, the giant British American Tobacco. The product incorporates Bespak's proprietary valve, and is designed to be a safer alternative to smoking.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.